학술논문
Selected subgroup analyses of liposomal irinotecan (nal-IRI) in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) in the global NAPOLI-1 phase III trial
Document Type
Article
Source
In: Annals of oncology : official journal of the European Society for Medical Oncology . (Annals of oncology : official journal of the European Society for Medical Oncology, 1 June 2018, 29:v101)
Subject
Language
English
ISSN
15698041